Personalized medecine

http://www.nature.com/nrn/journal/v5/n10/abs/nrn1518.html

http://www.jim.fr/medecin/jimplus/tribune/e-docs/oncologie_pediatrique_lenjeu_de_la_recherche_est_de_guerir_plus_denfants_et_mieux_151915/document_edito.phtml

La situation actuelle en matière d'information médicale est tellement paradoxale que le patient ou le client d'un service a vraisemblablement du mal a s'y retrouver. Exemple la question des nouveaux médicaments et des essais cliniques.
Contrairement à ce qui est souvent affirmé les essais cliniques ne sont ni l'apanage d ela modernité ni de la médecine anglosaxonne.
"Louis' first study of the topic was of the use of bloodletting in pneumonia, selecting 77 patients with a very similar form of pneumonia. After determining the timing of onset, duration and frequency of death rates of the disease, Louis then analyzed the timing of the bloodletting as either early (1–4 days since the start of the illness) or late (5–9 days). Based on these patients, Louis found that those who were bled early recovered earlier than those bled late, but also died at greater rates. Based on his findings, Louis concluded bloodletting was only a valid use in the late stages of disease. The ultimate impact of Louis' studies on the practice of medicine is hard to evaluate, as the practice of bloodletting was already beginning to decline when he published his results".
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383766/
http://gallica.bnf.fr/ark:/12148/bpt6k103986t/f1.image